Lipocine Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$734.97 | $636.99 | 19.73% | 9 | $661.77B |
JNJ | Johnson & Johnson | Outperform |
9
|
$149.27 | $174.55 | 13.89% | 3 | $359.25B |
MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.99B |
PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$401.08 | $457.59 | 12.57% | 11 | $103.66B |
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$957.00 | $961.26 | 9.72% | 8 | $105.45B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $89.17B |
ZTS | Zoetis | Outperform |
18
|
$167.07 | $220.47 | 34.08% | 5 | $76.34B |
ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$152.33 | $245.24 | 41.80% | 7 | $19.27B |
BAX | Baxter International Inc | Outperform |
17
|
$36.89 | $44.86 | 19.27% | 5 | $18.80B |
VTRS | Viatris Inc | Hold |
8
|
$11.78 | $11.73 | 6.11% | 5 | $13.74B |
UTHR | United Therapeutics | Outperform |
12
|
$262.40 | $284.08 | 14.33% | 3 | $11.64B |
CTLT | Catalent | Hold |
15
|
$56.50 | $49.29 | 12.39% | 3 | $10.23B |
CYTK | Cytokinetics | Outperform |
10
|
$65.27 | $87.92 | 44.02% | 11 | $6.84B |
IONS | Ionis Pharmaceuticals | Outperform |
9
|
$41.97 | $55.60 | 42.96% | 3 | $6.12B |
BCPC | Balchem | Outperform |
18
|
$150.40 | $145.00 | 8.38% | 1 | $4.56B |
PRGO | Perrigo Co PLC | Buy |
16
|
$32.79 | $44.75 | 21.99% | 0 | $4.43B |
MDGL | Madrigal Pharmaceuticals | Outperform |
4
|
$229.84 | $315.92 | 69.68% | 5 | $4.34B |
NEOG | Neogen | Outperform |
16
|
$12.02 | $37.00 | 41.43% | 0 | $2.67B |
INDV | Indivior PLC | Buy |
14
|
£14.35 | £28.89 | 115.54% | 4 | £1.95B |
CORT | Corcept Therapeutics | Buy |
16
|
$24.52 | $35.67 | 63.13% | 4 | $2.55B |
TGTX | TG Therapeutics | Outperform |
9
|
$16.19 | $29.44 | 113.09% | 6 | $2.38B |
AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.46 | $69.00 | 46.02% | 0 | $2.02B |
CPRX | Catalyst Pharmaceuticals | Buy |
16
|
$14.72 | $26.20 | 76.63% | 2 | $1.78B |
SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.83 | $41.00 | 29.74% | 0 | $1.66B |
ANIP | ANI Pharmaceuticals | Buy |
13
|
$67.25 | $69.75 | 18.96% | 1 | $1.38B |
IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$8.12 | $17.83 | 109.36% | 2 | $1.32B |
LGND | Ligand Pharmaceuticals | Outperform |
14
|
$73.90 | $111.83 | 48.85% | 3 | $1.26B |
ARPO | Aerpio Pharmaceuticals | - |
6
|
$30.30 | $330.00 | 15.51% | 0 | $1.24B |
COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.51 | $37.75 | 6.64% | 1 | $1.23B |
PCRX | Pacira BioSciences | Outperform |
16
|
$27.21 | $47.90 | 65.38% | 6 | $1.27B |
SAVA | Cassava Sciences | Outperform |
8
|
$22.05 | $124.00 | 351.25% | 1 | $957.89M |
ATRS | Antares Pharma | - |
8
|
$5.59 | $5.60 | 16.46% | 0 | $955.07M |
INVA | Innoviva | Hold |
16
|
$15.20 | $15.00 | -1.32% | 1 | $944.65M |
USNA | USANA Health Sciences | Hold |
14
|
$45.55 | $104.00 | 24.04% | 1 | $798.87M |
BSTC | BioSpecifics Technologies | - |
14
|
$0.00 | $88.50 | 0.00% | 0 | $647.97M |
BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | $10.00 | 16.46% | 0 | $577.05M |
ADMS | Adamas Pharmaceuticals | - |
7
|
$8.22 | $8.52 | -100.00% | 3 | $376.37M |
ESPR | Esperion Therapeutics | Outperform |
10
|
$2.08 | $8.19 | 284.62% | 1 | $393.95M |
NATR | Nature's Sunshine Products | Buy |
16
|
$19.06 | $21.50 | 25.92% | 1 | $358.69M |
HROW | Harrow | Buy |
12
|
$10.38 | $28.13 | 140.85% | 1 | $360.35M |
AERI | Aerie Pharmaceuticals | - |
7
|
$0.73 | $15.25 | -100.00% | 0 | $358.35M |
ZVRA | Zevra Therapeutics | Buy |
10
|
$4.81 | $19.50 | 284.62% | 1 | $253.06M |
RCEL | AVITA Medical | Buy |
6
|
$8.75 | $37.39 | 286.51% | 6 | $222.91M |
ATOS | Atossa Genetics Inc | Buy |
5
|
$1.66 | $4.83 | 140.96% | 0 | $219.28M |
AVM | AMAG Pharmaceuticals | - |
2
|
$314.00 | $13.75 | -100.00% | 0 | $211.76M |
ALIM | Alimera Sciences | Buy |
9
|
$3.65 | $7.00 | 119.18% | 3 | $185.33M |
RIGL | Rigel Pharmaceuticals | Outperform |
4
|
$1.20 | $4.04 | 108.33% | 3 | $184.15M |
NKTR | Nektar Therapeutics | Hold |
11
|
$1.57 | $2.75 | -36.31% | 2 | $171.69M |
PRTK | Paratek Pharmaceuticals | - |
2
|
$2.21 | $2.15 | -100.00% | 2 | $143.19M |
KPTI | Karyopharm Therapeutics | Outperform |
6
|
$1.13 | $6.00 | 342.48% | 1 | $131.61M |
CTXR | Citius Pharmaceuticals | Outperform |
4
|
$0.71 | $3.17 | 463.38% | 0 | $133.90M |
SCTL | Societal CDMO | - |
9
|
$1.10 | $1.86 | -100.00% | 1 | $116.26M |
AGEN | Agenus | Buy |
8
|
$13.07 | $6.67 | 512.09% | 2 | $111.22M |
GALT | Galectin Therapeutics | Outperform |
6
|
$1.74 | $11.00 | 532.18% | 0 | $102.05M |
SNSS | Sunesis Pharmaceuticals | - |
2
|
$0.00 | $42.00 | 0.00% | 0 | $96.26M |
ASRT | Assertio Holdings | Buy |
8
|
$1.03 | $3.50 | 191.26% | 2 | $88.49M |
CBLI | Cleveland BioLabs | - |
4
|
$3.42 | $40.00 | -100.00% | 0 | $84.62M |
EGRX | Eagle Pharmaceuticals | - |
14
|
$4.41 | $17.00 | -100.00% | 0 | $84.16M |
LFVN | LifeVantage |
0
|
$6.57 | $7.00 | -100.00% | 0 | $78.50M | |
AKN | Akorn Operating Company LLC | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $70.85M |
OPNT | Opiant Pharmaceuticals | - |
10
|
$20.77 | $21.00 | -100.00% | 0 | $63.99M |
MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $56.27M |
FBIO | Fortress Biotech | Buy |
11
|
$1.75 | $67.50 | 328.57% | 1 | $33.66M |
IGC | IGC Pharma | Buy |
4
|
$0.51 | $3.05 | 537.25% | 0 | $32.37M |
NBEV.Q | NewAge | - |
6
|
$0.00 | $3.50 | 0.00% | 0 | $29.73M |
DRRX | DURECT | Outperform |
9
|
$1.16 | $6.75 | 481.90% | 2 | $36.00M |
DARE | Daré Bioscience | Outperform |
5
|
$0.31 | $4.00 | 1835.48% | 1 | $28.16M |
TXMD | TherapeuticsMD | - |
5
|
$2.26 | $5.00 | 3.10% | 0 | $27.14M |
ACER | Acer Therapeutics | - |
0
|
$0.66 | $12.00 | -100.00% | 0 | $23.28M |
LCI | Lannett Company | - |
10
|
$0.03 | $4.00 | -100.00% | 1 | $21.85M |
MEIP | MEI Pharma | Outperform |
10
|
$3.06 | $23.33 | 553.59% | 1 | $21.65M |
ACRX | AcelRx Pharmaceuticals | Buy |
6
|
$1.02 | $4.63 | 402.94% | 0 | $21.53M |
JAGX | Jaguar Health | - |
0
|
$0.08 | $5.88 | -50.00% | 0 | $17.40M |
COCP | Cocrystal Pharma | Buy |
0
|
$1.63 | $8.33 | 513.50% | 1 | $15.67M |
CNSP | CNS Pharmaceuticals | - |
0
|
$0.29 | $6.25 | -44.83% | 0 | $11.81M |
MYOS | MYOS RENS Technology | - |
0
|
$0.00 | $45.00 | 0.00% | 0 | $11.56M |
GHSI | Guardion Health Sciences | Hold |
0
|
$8.00 | $12.00 | -100.00% | 1 | $10.26M |
TOVX | Theriva Biologics | Buy |
2
|
$0.40 | $4.50 | 1025.00% | 1 | $8.43M |
ADIL | Adial Pharmaceuticals | Outperform |
0
|
$1.70 | $17.00 | 341.18% | 2 | $7.83M |
AVTX | Avalo Therapeutics | Hold |
0
|
$4.46 | $0.00 | -45.29% | 0 | $7.79M |
SNGX | Soligenix | Buy |
6
|
$0.40 | $3.25 | 775.00% | 0 | $7.56M |
ATXI | Avenue Therapeutics | Buy |
-7
|
$4.78 | $16.38 | 25593.10% | 0 | $5.50M |
KPRX | Kiora Pharmaceuticals | Outperform |
11
|
$0.51 | $12.83 | 488.24% | 2 | $4.86M |
FRTX | Fresh Tracks Therapeutics | - |
-8
|
$0.99 | $0.00 | -100.00% | 0 | $4.59M |
EVOK | Evoke Pharma | Outperform |
6
|
$0.49 | $7.00 | 1328.57% | 1 | $3.97M |
ARTL | Artelo Biosciences | Outperform |
-14
|
$1.67 | $0.00 | 199.40% | 0 | $3.88M |
AGRX | Agile Therapeutics | - |
7
|
$0.38 | $8.50 | -100.00% | 0 | $2.61M |
NBY | NovaBay Pharmaceuticals | Buy |
-9
|
$0.09 | $3.65 | 2788.89% | 1 | $2.48M |
VVUS.Q | VIVUS | - |
0
|
$0.00 | $2.50 | 0.00% | 0 | $2.26M |
YCBD | cbdMD | Outperform |
0
|
$0.86 | $3.00 | 132.56% | 1 | $2.13M |
AMPE | Ampio Pharmaceuticals | - |
0
|
$1.71 | $0.00 | -100.00% | 0 | $1.76M |
EVFM | Evofem Biosciences | Hold |
0
|
$0.01 | $225.00 | -100.00% | 1 | $0.73M |
ZSAN.Q | Zosano Pharma | - |
6
|
$0.00 | $1.00 | 0.00% | 0 | $0.50M |
DMK | DMK Pharmaceuticals | - |
8
|
$0.05 | $1.50 | -100.00% | 0 | $0.35M |
IG | Teligent | - |
2
|
$0.00 | $1.00 | 0.00% | 0 | $0.02M |
TMBR.Q | Timber Pharmaceuticals | - |
0
|
$0.00 | $11.00 | 0.00% | 0 | $0.00M |
FLXN | Flexion Therapeutics | - |
0
|
$9.25 | $10.00 | -100.00% | 0 | $0.00M |
ZGNX | Zogenix | - |
0
|
$0.00 | $27.00 | 0.00% | 0 | $0.00M |
INFI.Q | Infinity Pharmaceuticals | - |
7
|
$0.00 | $0.30 | 0.00% | 1 | $0.00M |